Patient Guide: Evaluation of the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of BBM-C101 Injection in Patients With Cervical High-Grade Squamous Intraepithelial Lesion(HSIL)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 4 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07668960
Status: UPCOMING
Condition: High-grade Squamous Intraepithelial Lesions of the Cervix Associated With Human Papillomavirus (HPV) Type 16 and/or HPV Type 18 Infection
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 4 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Beijing, Beijing Municipality
  • Chongqing, Chongqing Municipality
  • Zhangzhou, Henan
  • • And 1 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily